ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation

This study has been completed.
Sponsor:
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00888875
First received: April 27, 2009
Last updated: November 15, 2010
Last verified: November 2010

April 27, 2009
November 15, 2010
July 2008
April 2010   (final data collection date for primary outcome measure)
successful intubation attempt with ventilation of both lungs [ Time Frame: during intervention ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00888875 on ClinicalTrials.gov Archive Site
  • insertion of supraglottic airway devices, the time to intubate, airway device leak pressure, adverse events and postoperative side effects [ Time Frame: during intervention and first 24hours after operation ] [ Designated as safety issue: Yes ]
  • simulated blind intubation in both groups [ Time Frame: during intervention ] [ Designated as safety issue: No ]
insertion of supraglottic airway devices, the time to intubate, airway device leak pressure, adverse events and postoperative side effects [ Time Frame: during intervention and first 24hours after operation ] [ Designated as safety issue: Yes ]
Not Provided
Not Provided
 
ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation
Is Fiberoptic Intubation Through the I-gel™ Equal to Fiberoptic Intubation Through the Intubating Laryngeal Mask (Fastrach)™ ?

We evaluate feasibility of fiberoptic intubation through the "ILMA Fastrach" vs the "i-gel". Both are airway devices to be introduced in the mouth we the possibility to ventilate the patient and furthermore to be a guide to introduce a tracheal tube. We first insert either the ILMA or the i-gel. In a second step, we will introduce a tube through the device, all guided visually through a fiberoptic tool which works as a railroad for the tracheal tube.

The ILMA Fastrach™ is a widely accepted and intensively investigated supraglottic airway device that is inserted blindly. It may be used to facilitate intubation and secure the airway in routine practice, in difficult airway scenarios or in emergency situations. Endotracheal tube insertion may be blind or fiberoptic scope guided, the latter raises the success rate. The i-gel™ is a newly developed supraglottic airway device and is also introduced blindly. Insertion of an endotracheal tube may be blind or fiberoptically guided.

So far, prospective randomized controlled trials comparing their performance are not yet published. There are case reports about intubating over the i-gel.

In this prospective, randomized, controlled trial, we are going to evaluate the performance of intubation through both devices. In 250 patients undergoing elective surgery, we will place either the ILMA or the i-gel according to randomization and then intubate with the help of a fiberoptic scope, using the specific ILMA tracheal tube or a normal tracheal tube for the i-gel. In order to remove the supraglottic airway devices, we will use the ILMA stabilizer rod.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Tracheal Intubation
  • Device: i-gel
    insertion after induction of anaesthesia. Afterwards, intubation over the device fiberoptically
  • Device: ILMA
    Insertion after Induction. Insertion of tracheal tube over device
  • Experimental: 1
    Computer randomized insertion of the i-gel. Intubation fiberoptically of a tracheal tube
    Intervention: Device: i-gel
  • Active Comparator: 2
    Computer randomized insertion of the i-gel. Intubation fiberoptically of a tracheal tube
    Intervention: Device: ILMA
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
240
May 2010
April 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • elective operation with intubation
  • ASA I-IV
  • speaks German
  • at least one predictor for difficult intubation

Exclusion Criteria:

  • weight <30kg
  • Risk Aspiration
  • Risk bleeding orally
  • known or highly suspected difficult mask ventilation
  • Mouth opening < 20mm
Both
18 Years to 85 Years
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT00888875
Fast igel1
No
Robert Greif, M.D. Associate Professor, Department of Anesthesia, University Hospital Inselspital, Berne, Switzerland
University Hospital Inselspital, Berne
Not Provided
Study Director: Robert Greif, M.D. Department of Anesthesia, University Hospital Berne, Switzerland
University Hospital Inselspital, Berne
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP